BDT Capital Partners acquires minority stake in Exyte

- The partnership will strengthen Exyte's long-term strategy as a global leader in the planning, development, and construction of high-tech facilities
- Exyte serves technically demanding clients in growth industries such as semiconductor, battery, biotech, and pharmaceutical sectors, as well as in data centers
- Exyte makes progress on its growth path "Pathway to Ten" with a planned annual turnover of ten billion euros by 2027

Exyte, a world leader in the planning, development, and delivery of high-tech facilities, announces that funds affiliated with BDT Capital Partners, LLC ("BDT") have reached an agreement to acquire a significant minority stake in Exyte. BDT is a merchant bank that provides advice and long-term capital through its affiliated funds to family- and founder-led companies, enabling them to pursue their strategic and financial goals. BDT will become a minority owner of Exyte alongside Georg Stumpf, the current sole owner of Exyte, who will continue to hold the majority shares.

Don McLellan, Partner at BDT, says: “Exyte is a leading company in the planning, development, and construction of the world's most demanding production environments. The company plays an indispensable role in supporting clients from the semiconductor, biopharma, life sciences, and cloud computing industries in establishing first-class manufacturing facilities and buildings where technological breakthroughs are achieved. Thanks to the strong leadership of Exyte’s management team and the commitment of its excellent employees, the company can boast an impressive track record of profitable growth. We look forward to working with Georg Stumpf and the Exyte management team to strengthen growth and continue the company's success story.”

Georg Stumpf, who will remain the majority owner of Exyte, says: “Exyte works for the most technically demanding clients in booming growth industries. The company is the driving force behind important megatrends of today and tomorrow. Exyte enables developments that fundamentally change the lives of individuals and society, while also advancing digitalization and connectivity, e-mobility, renewable energies, digital health services, and personalized healthcare. Since I took over the company in 2008, Exyte has exceeded all expectations. The company will again record record sales and results in 2022. I look forward to continuing to support Exyte’s successful strategy and future growth together with BDT.”

Dr. Wolfgang Büchele, CEO of Exyte, says: “Our clear focus on high-tech industries is paying off. Thanks to the favorable market outlook and our focus on semiconductors and batteries, biopharma and life sciences, as well as data centers, we are well positioned in our markets. We are successfully pursuing our growth path “Pathway to Ten.” This year, we will again surpass our target with seven billion euros in revenue and approach the planned ten billion euros by 2027. Given our ongoing successful projects and our well-filled project pipeline, we are well prepared for future profitable growth. I am pleased that BDT is convinced of Exyte’s potential and will accompany us on our journey.”

The completion of the transaction is subject to the usual regulatory approvals. Financial details will not be disclosed. Deutsche Bank advised Exyte in connection with the transaction.